These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Combination of minimally invasive thyroid surgery and local anesthesia associated to iopanoic acid for patients with amiodarone-induced thyrotoxicosis and severe cardiac disorders: a pilot study. Berti P; Materazzi G; Bogazzi F; Ambrosini CE; Martino E; Miccoli P Langenbecks Arch Surg; 2007 Nov; 392(6):709-13. PubMed ID: 17103224 [TBL] [Abstract][Full Text] [Related]
6. Amiodarone-induced thyrotoxicosis. A review. Piga M; Serra A; Boi F; Tanda ML; Martino E; Mariotti S Minerva Endocrinol; 2008 Sep; 33(3):213-28. PubMed ID: 18846027 [TBL] [Abstract][Full Text] [Related]
8. Rapid preparation of severe uncontrolled thyrotoxicosis due to Graves' disease with Iopanoic acid--a case report. Pandey CK; Raza M; Dhiraaj S; Agarwal A; Singh PK Can J Anaesth; 2004 Jan; 51(1):38-40. PubMed ID: 14709458 [TBL] [Abstract][Full Text] [Related]
9. Preoperative therapeutic apheresis for severe medically refractory amiodarone-induced thyrotoxicosis: a case report. Yamamoto J; Dostmohamed H; Schacter I; Ariano RE; Houston DS; Lewis B; Knoll C; Katz P; Zarychanski R J Clin Apher; 2014 Jun; 29(3):168-70. PubMed ID: 24265247 [TBL] [Abstract][Full Text] [Related]
10. Management of amiodarone-induced thyrotoxicosis in Latin America: an electronic survey. Diehl LA; Romaldini JH; Graf H; Bartalena L; Martino E; Albino CC; Wiersinga WM Clin Endocrinol (Oxf); 2006 Oct; 65(4):433-8. PubMed ID: 16984234 [TBL] [Abstract][Full Text] [Related]
11. Drug-induced thyrotoxicosis: the surgical option. Lorberboym M; Schachter P Isr Med Assoc J; 2007 Feb; 9(2):79-82. PubMed ID: 17348476 [TBL] [Abstract][Full Text] [Related]
12. Amiodarone-induced thyrotoxicosis in a patient with autonomously functioning nodular goiter. Liang YL; Huang SM; Peng SL; Hsiao SH; Hung HC; Ou HY; Wu TJ Ann Pharmacother; 2009 Jan; 43(1):134-8. PubMed ID: 19109209 [TBL] [Abstract][Full Text] [Related]
15. Impact of thyroid metabolism on the course of INR levels in a patient with systemic anticoagulation suffering from amiodarone-induced thyrotoxicosis. Bucerius J; Ezziddin S; Brockmann H; Palmedo H; Biersack HJ Exp Clin Endocrinol Diabetes; 2007 Oct; 115(9):606-9. PubMed ID: 17943696 [TBL] [Abstract][Full Text] [Related]
16. Diagnosis and management of amiodarone-induced thyrotoxicosis in Europe: results of an international survey among members of the European Thyroid Association. Bartalena L; Wiersinga WM; Tanda ML; Bogazzi F; Piantanida E; Lai A; Martino E Clin Endocrinol (Oxf); 2004 Oct; 61(4):494-502. PubMed ID: 15473883 [TBL] [Abstract][Full Text] [Related]
18. Total thyroidectomy in amiodarone-induced thyrotoxicosis. Preoperative, intraoperative and postoperative considerations. Batori M; Nardi M; Chatelou E; Straniero A; Makrypodi M; Ruggieri M Eur Rev Med Pharmacol Sci; 2006; 10(4):187-90. PubMed ID: 16910349 [TBL] [Abstract][Full Text] [Related]
19. The therapeutic efficacy of oral cholecystographic agent (iopanoic acid) in the management of hyperthyroidism. Bal C; Nair N J Nucl Med; 1990 Jul; 31(7):1180-2. PubMed ID: 2194004 [TBL] [Abstract][Full Text] [Related]
20. Amiodarone-induced thyroid dysfunction in cardiac patients from areas with iodine deficiency. Trifănescu R; Fica S; Barbu C; Vârtej I; Ursu H; Bunghez R; Coculescu M Rom J Intern Med; 2004; 42(3):595-605. PubMed ID: 16366133 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]